NEWS ARCHIVE
“Tocotrienol: Matters of The Heart” featured in Asia Pacific Food Industry
Instead of focusing on treating the symptoms of heart disease, people are seeking strategies to prevent heart disease from developing in the first place. By Dr Tieh Koun Koh, director of sales & marketing, Davos Life Sciences.
Davos’s Scientists presented in American Association of Cancer Research 101st Annual Meeting 2010
Our results suggested that the anti-proliferative and chemosensitization effect of gamma-tocotrienol on BCa cells may be mediated through downregulation of Id1 protein.
Scientists discover tocotrienol has a common cancer-killing mechanism
Our results indicate that γT3, either alone or in combination with DTX, may provide a treatment strategy that can improve therapeutic efficacy against AIPCa while reducing the toxicity often seen in patients treated with DTX.